echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Lancet: Aspirin May Reduce Colon Cancer Risk in People With Lynch Syndrome

    Lancet: Aspirin May Reduce Colon Cancer Risk in People With Lynch Syndrome

    • Last Update: 2020-06-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Lynch syndrome is associated with an increased risk of many tumors, especially endometrial cancerIn 2011, researchers examined the long-term effects of daily aspirin use on tumorpreventionin people with Lynch syndrome, and after an average follow-up of 55.7 months, researchers recently published a long-term assessment of regular aspirin useCAPP2 trial, 861 people with Lynch syndrome from 43 centres worldwide (707 in Europe, 82 per cent; 112 in Australia, 13 per cent; 38 in Africa, 4 per cent; and 4 in the Americas, 1 per cent) were randomly taken daily with 600 mg of aspirin or a placeboThe main endpoint iscolorectal cancerdiagnosed861 Lynch syndrome patients with an average age of 45 were involved in the study, of which 427 (50%) of participants received aspirin and 434 (50%) received placebo treatmentThe average follow-up was 10 years, about 8,500 people-yearsForty (9%) of the 427 subjects who took aspirin developed colorectal cancer, while 58 (13%) of the 434 placebo subjects developed colorectal cancerCox proportional risk analysis showed a significant lying risk of aspirin compared to placebo (0.65) and a negative two regression analyses showed a reduced risk (0.58)An analysis of 509 participants who received two years of intervention showed an HR of 0.56 and a incidence rate of 0.50The difference in the rate of adverse events between groups was not significantresearch supported, people with Lynch syndrome take aspirin to prevent colorectal cancer
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.